The presentation to be covered is ‘Percutaneous Left Atrial Appendage Closure‘ presented by Dr. Jacqueline Saw, Interventional Cardiologist, Vancouver General Hospital (VGH), CA.
This free-to-attend interactive webinar is targeted at interventional cardiologists, electrophysiologists, general internist and family physicians but is also open to other cardiologists wishing to update their scientific knowledge on the topic.
| RC Webinar – Percutaneous Left Atrial Appendage Closure |
| Thursday 7th May 2015, 4pm GMT |
|
|
|
 EDUCATIONAL OBJECTIVES
This webinar is to inform and educate interventional cardiologists and cardiac surgeons on:
- Epidemiology of atrial fibrillation and stroke risk
- Left atrial appendage closure: surgical and percutaneous approaches
- Randomized controlled trial data with WATCHMAN
- Percutaneous devices for LAA closure
- Safety and efficacy of LAA closure
OVERVIEW
Left atrial appendage (LAA) closure is a rapidly emerging field in stroke prevention for patients with atrial fibrillation. Several percutaneous and surgical devices are now approved worldwide, and many more are in clinical development and being evaluated in research trials. The current most widely used endovascular devices worldwide are the WATCHMAN and Amplatzer Cardiac Plug (Amulet, 2nd generation) devices, which received CE Mark in 2005 and 2008, respectively. In addition, the WATCHMAN device recently received FDA approval in March 2015 in the United States for patients at high-risk of stroke who are suitable for warfarin, and who have appropriate rationale for non-pharmacologic stroke prevention alternative… [ Read More ]
|
Presented by
